cloudfront

Report Detail



2015-2023 World Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Research Report by Product Type, End-User / Application and Regions / Countries

Table of Contents

    1 Market Definition

    • 1.1 Market Segment Overview
    • 1.2 by Type
    • 1.3 by End-Use / Application

    2 Global Market by Vendors

    • 2.1 Market Share
    • 2.2 Vendor Profile
    • 2.3 Dynamic of Vendors

    3 Global Market by Type

    • 3.1 Market Share
    • 3.2 Introduction of End-Use by Different Products

    4 Global Market by End-Use / Application

    • 4.1 Market Share
    • 4.2 Overview of Consumption Characteristics
      • 4.2.1 Preference Driven
      • 4.2.2 Substitutability
      • 4.2.3 Influence by Strategy
      • 4.2.4 Professional Needs

    5 Global Market by Regions

    • 5.1 Market Share
    • 5.2 Regional Market Growth
      • 5.2.1 North America
      • 5.2.2 Europe
      • 5.2.3 Asia-Pacific
      • 5.2.4 South America
      • 5.2.5 Middle East & Africa

    6 North America Market

    • 6.1 by Type
    • 6.2 by End-Use / Application
    • 6.3 by Regions

    7 Europe Market

    • 7.1 by Type
    • 7.2 by End-Use / Application
    • 7.3 by Regions

    8 Asia-Pacific Market

    • 8.1 by Type
    • 8.2 by End-Use / Application
    • 8.3 by Regions

    9 South America Market

    • 9.1 by Type
    • 9.2 by End-Use / Application
    • 9.3 by Regions

    10 Middle East & Africa Market

    • 10.1 by Type
    • 10.2 by End-Use / Application
    • 10.3 by Regions

    11 Market Forecast

    • 11.1 Global Market Forecast (2018-2023)
    • 11.2 Market Forecast by Regions (2018-2023)
    • 11.3 Market Forecast by Type (2018-2023)
    • 11.4 Market Forecast by End-Use / Application (2018-2023)

    12 Key Manufacturers

    • 12.1 Amgen Inc
      • 12.1.2 Company Overview
      • 12.1.2 Product and End-User / Application
      • 12.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
    • 12.2 Amorepacific Corp
      • 12.2.1 Company Overview
      • 12.2.2 Product and End-User / Application
      • 12.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
    • 12.3 BCN Peptides SA
      • 12.3.1 Company Overview
      • 12.3.2 Product and End-User / Application
      • 12.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
    • 12.4 Centrexion Therapeutics Corp
      • 12.4.1 Company Overview
      • 12.4.2 Product and End-User / Application
      • 12.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
    • 12.5 Daewoong Pharmaceutical Co Ltd
      • 12.5.1 Company Overview
      • 12.5.2 Product and End-User / Application
      • 12.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
    • 12.6 DoNatur GmbH
      • 12.12.1 Company Overview
      • 12.12.2 Product and End-User / Application
      • 12.12.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
    • 12.7 Flex Pharma Inc
      • 12.7.1 Company Overview
      • 12.7.2 Product and End-User / Application
      • 12.7.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
    • 12.8 Grunenthal GmbH
      • 12.8.1 Company Overview
      • 12.8.2 Product and End-User / Application
      • 12.8.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
    • 12.9 Kyowa Hakko Kirin Co Ltd
      • 12.9.1 Company Overview
      • 12.9.2 Product and End-User / Application
      • 12.9.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
    • 12.10 Medifron DBT Co Ltd
      • 12.10.1 Company Overview
      • 12.10.2 Product and End-User / Application
      • 12.10.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
    • 12.11 Neurim Pharmaceuticals Ltd
    • 12.12 Pila Pharma AB
    • 12.13 Sylentis SAU
    • 12.14 Toray Industries Inc
    • 12.15 Vitality Biopharma Inc

    13 Price Overview

    • 13.1 Price Segment
    • 13.2 Price Trend

    14 Research Conclusion

    Summary
    This report includes market status and forecast of global and major regions, with introduction of vendors, regions, product types and end industries; and this report counts product types and end industries in global and major regions.
    Market Segment as follows:
    By Region / Countries
    North America (U.S., Canada, Mexico)
    Europe (Germany, U.K., France, Italy, Russia, Spain etc)
    South America (Brazil, Argentina etc)
    Middle East & Africa (Saudi Arabia, South Africa etc)
    By Type
    CMX-020
    CA-016
    DD-04107
    Others
    By End-User / Application
    Ophthalmology
    Immunology
    Muscle Spasm
    Pruritus
    Abdominal Pain
    Others
    By Company
    Amgen Inc
    Amorepacific Corp
    BCN Peptides SA
    Centrexion Therapeutics Corp
    Daewoong Pharmaceutical Co Ltd
    DoNatur GmbH
    Flex Pharma Inc
    Grunenthal GmbH
    Kyowa Hakko Kirin Co Ltd
    Medifron DBT Co Ltd
    Neurim Pharmaceuticals Ltd
    Pila Pharma AB
    Sylentis SAU
    Toray Industries Inc
    Vitality Biopharma Inc




    Summary:
    Get latest Market Research Reports on Transient Receptor Potential Cation Channel Subfamily V Member 1 . Industry analysis & Market Report on Transient Receptor Potential Cation Channel Subfamily V Member 1 is a syndicated market report, published as 2015-2023 World Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Research Report by Product Type, End-User / Application and Regions / Countries. It is complete Research Study and Industry Analysis of Transient Receptor Potential Cation Channel Subfamily V Member 1 market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.


    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $2,800.00
    $5,600.00
    1,880.20
    3,760.40
    2,576.56
    5,153.12
    339,192.00
    678,384.00
    185,677.52
    371,355.04
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report